Retraction: Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer

IF 5.8 3区医学 Q1 MATERIALS SCIENCE, BIOMATERIALS

Biomaterials Science Pub Date : 2024-10-15 DOI:10.1039/D4BM90079K

Chunpu Li, Gang Cai, Daqian Song, Ruixuan Gao, Peng Teng, LiHong Zhou, Qing Ji, Hua Sui, Jianfeng Cai, Qi Li and Yan Wang

引用次数: 0

Abstract

Retraction of ‘Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer’ by Chunpu Li et al., Biomater. Sci., 2019, 7, 3627–3639, https://doi.org/10.1039/C9BM00613C.

查看原文本刊更多论文

撤回：开发用于治疗结直肠癌的表皮生长因子受体靶向 evodiamine 纳米粒子。

撤销李春璞等人的 "用于治疗结直肠癌的表皮生长因子受体靶向evodiamine纳米颗粒的开发"，Biomater.Sci.，2019，7，3627-3639，https://doi.org/10.1039/C9BM00613C。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Biomaterials Science MATERIALS SCIENCE, BIOMATERIALS-

CiteScore

11.50

自引率

4.50%

发文量

556

期刊介绍： Biomaterials Science is an international high impact journal exploring the science of biomaterials and their translation towards clinical use. Its scope encompasses new concepts in biomaterials design, studies into the interaction of biomaterials with the body, and the use of materials to answer fundamental biological questions.